The significance of biological, environmental, and social risk factors for prostate cancer in a cohort study in brazil

International Braz J Urol

Volumn 38, Issue 6, 2012, Pages 769-778

  Romero, Frederico R ^a,b,c,d   Romero, Antonio W ^a   De Almeida, Rui Manuel S ^b   De Oliveira, Fernando Cesar ^c   Filho, Renato Tambara ^d  

^a Hospital Policlínica Cascavel   (Brazil)

^b Faculdade Assis Gurgacz   (Brazil)

^c Cascavel Instituto Curitiba de Saúde   (Brazil)

^d FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Epidemiology; Population groups; Prevalence; Prostatic neoplasms

Indexed keywords

EID: 84874915588     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/1677-553820133806769     Document Type: Article

References (25)

1. Klein EA, Platz EA, Thompson IM, Epidemiology, etiology, and prevention of prostate cancer. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (ed.), Campbell-Walsh urology, 9th ed. Philadelphia, Saunders Elsevier. 2007; pp. 2854-7.
2. Haas GP, Sakr WA, Epidemiology of prostate cancer. CA Cancer J Clin. 1997; 47: 273-87.
3. Miller BA, Kolonel LN, Bernstein L, Young JL, Swanson GM, West DW, et al.: Racial/ethnic patterns of cancer in the United States 1988-1992. Bethesda, MD: National Cancer Institute. 1996; pp. 96-4104.
4. National Cancer Institute: Genetics of prostate cancer. Available at: URL: http://www.cancer.gov/cancertopics/ pdq/genetics/prostate/HealthProfessional#Section_ Last accessed: September 18, 2012.
5. Bouchardy C, Mirra AP, Khlat M, Parkin DM, de Souza JM, Gotlieb SL, Ethnicity and cancer risk in São Paulo, Brazil. Cancer Epidemiol Biomarkers Prev. 1991; 1: 21-7.
6. Ben-Shlomo Y, Evans S, Patel B, Anson K, Muir G, Persad R, et al.: Differences in the epidemiology and presentation of prostate cancer in Black and White men in England: lessons learnt from the process study. BJU Int. 2009; 103: 723-4.
7. Jack RH, Davies EA, Møller H, Prostate cancer incidence, stage at diagnosis, treatment and survival in ethnic groups in South-East England. BJU Int. 2010; 105: 1226-30.
8. Martins AC, Reis RB, Suaid HJ, Maciel LM, Cologna AJ, Falconi RA, Screening for carcinoma of the prostate in volunteers. Int Braz J Urol. 2000; 26:516-22.
9. Antonopoulos IM, Pompeo AC, Hayek OR, Sarkis AS, Alfer Jr W, Arap S, Results of prostate cancer screening in nonsymptomatic men. Int Braz J Urol. 2001; 27:227-34.
10. Glina S, Toscano IL Jr, Mello JF, Martins FG, Vieira VL, Damas CG, Results of screening for prostate cancer in a community hospital. Int Braz J Urol. 2001; 27:235-43.
11. Barros MS, Silva VR, Santos GB, Hughes A, Silveira MA, Prevalence of prostate adenocarcinoma according to race in an university hospital. Int Braz J Urol. 2003; 29: 306-11; discussion 312.
12. Romero FR, Romero AW, de Almeida RM, Tambara Filho R, The prevalence of prostate cancer in Brazil is higher in Black men than in White men: systematic review and metaanalysis. Int Braz J Urol. 2012; 38: 440-7.
13. Paschoalin EL, Martins AC, Pastorello M, Sândis KA, Maciel LM, Silva WA Jr, et al. Racial influence on the prevalence of prostate carcinoma in Brazilian volunteers. Int Braz J Urol. 2003; 29: 300-5.
14. Johns LE, Houlston RS, A systematic review and metaanalysis of familial prostate cancer risk. BJU Int. 2003; 91: 789-94.
15. Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P, Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer. 2003; 107: 797-803.
16. Ferrís-I-Tortajada J, Berbel-Tornero O, Garcia-I-Castell J, López-Andreu JA, Sobrino-Najul E, Ortega-García JÁ, Non dietetic environmental risk factors in prostate cancer. Actas Urol Esp. 2011; 35: 289-95.
17. Dennis LK, Dawson DV, Resnick MI, Vasectomy and the risk of prostate cancer: a meta-analysis examining vasectomy status, age at vasectomy, and time since vasectomy. Prostate Cancer Prostatic Dis. 2002; 5: 193-203.
18. Tang LF, Jiang H, Shang XJ, Zhao LM, Bai Q, Hong K, et al. Vasectomy not associated with prostate cancer: a metaanalysis. Zhonghua Nan Ke Xue. 2009; 15: 545-50.
19. Sharlip ID, Vasectomy: American Urological Association (AUA) Guideline. Linthicum: AUA Foundation, 2012. Available at: URL: http://www.auanet.org/content/media/vasectomy. pdf. Last accessed: September 18,2012.
20. Martin RM, Vatten L, Gunnell D, Romundstad P, Blood pressure and risk of prostate cancer: Cohort Norway (CONOR). Cancer Causes Control. 2010; 21: 463-72.
21. de Santana IA, Moura GS, Vieira NF, Cipolotti R, Metabolic syndrome in patients with prostate cancer. Sao Paulo Med J. 2008; 126: 274-8.
22. Kasper JS, Giovannucci E, A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15: 2056-62.
23. Bonovas S, Filioussi K, Tsantes A, Diabetes mellitus and risk of prostate cancer: a meta-analysis. Diabetologia. 2004; 47: 1071-8.
24. Taylor ML, Mainous AG 3rd, Wells BJ, Prostate cancer and sexually transmitted diseases: a meta-analysis. Fam Med. 2005; 37: 506-12.
25. Brazil, Ministry of Health, National Cancer Institute: Coordination of prevention and surveillance. Household survey on risk behaviors and morbidity of diseases and nontrasmissible diseases: Brazil, 15 capital and Federal District, 2002-2003. Rio de Janeiro: INCA, 2004. Available at: URL: http:// www.inca.gov.br/inquerito/docs/completa.pdf. Last accessed: September 18, 2012.